SOLMIRA SARS-COV-2&INFL A/B
4.17€
- Brand: T TEX Srl
- Product Code: 985914264
- EAN: 6971348761967
- Availability: Out Of Stock
- Purchase 3 items for 4.09€ each
- Purchase 4 items for 4.00€ each
- Purchase 5 items for 3.92€ each
SOLMIRA
Description
SARS-CoV-2 & Influenza A/B & RSV Combined Antigen Test Kit, intended for the qualitative detection and simultaneous differentiation of novel coronavirus (SARS-CoV-2 antigen), influenza A virus and influenza B virus antigen and /or RSV antigen in samples collected by in vitro nasal swab.
It can be used as a reference for the diagnosis of coronavirus infectious disease (COVID-19) caused by SARS-CoV-2 detected in symptomatic individuals within 7 days of when the syndromes appear. It can also be used as a reference when diagnosing illnesses caused by influenza A/B or RSV.
For in vitro diagnostics only.
The SARS-CoV-2 & Influenza A/B & RSV antigen is qualitatively detected in the samples collected through nasal swabs with the colloidal gold method. After sample addition, SARS-CoV-2 (or Influenza A/B & RSV) antigen in test sample combines with SARS-CoV-2 (or Influenza A/B & RSV) antigen antibody labeled with colloidal gold on the junction plate to form the SARS-CoV-2 (or Influenza A/B & RSV) antigen antibody-colloidal gold complex. By chromatography, the antibody-colloidal gold complex of the SARS-CoV-2 (or Influenza A/B & RSV) antigen diffuses along the nitrocellulose membrane. Within the detection line area, the antibody complex of SARS-CoV-2 (or Influenza A/B & RSV) antigen binds to the antibody enclosed within the detection line area, showing a purple-red band. The SARS-CoV antigen colloidal gold-labeled antibody -2 (or Influenza A/B & RSV) spreads in the QC line area (C) and is captured by sheep anti-mouse IgG to form red bands. At the end of the reaction, the results can be interpreted by visual inspection.
How to use
Use a hand sanitizer to disinfect your hands after washing them.
Clean the table top on which the test will be performed.
Before performing the test, read the instructions for use carefully, and allow the test kit and samples to reach room temperature (20-25°C) before use. The test must be performed at 20-25°C. If the kit is removed from the refrigerator, allow it to return to room temperature (20-25°C) 5 minutes before performing the test.
1. Unscrew the cap of the Sample Processing tube and remove the inner blue cap. The purpose of the blue cap is to prevent the product from escaping during transport, the blue cap must be removed before use. Insert the treatment tube into the hole in the kit or use other objects to hold the treatment tube in place.
2. Open the foil pouch, take out the test cassette and use it as soon as possible, i.e. within 1 hour.
3. Sample collection
to. Carefully remove the sterile nasal swab from its packaging (avoid touching the cotton end of the swab). Insert the nasal swab 2.5 cm (1 inch) into the left nostril.
b. Roll the nasal swab over the nasal walls (mucous membrane) 5 times to ensure that sampling was successful.
c. Repeat the procedure in the right nostril with the same nasal swab, in order to take a sample from both nostrils and make sure that the sampling has taken place correctly.
4. Insert the swab sample into the tube, then break the swab stick and insert the bottom of the swab into the processing tube. Replace the cap.
5. Squeeze the swab 10 times against the side of the tube, then wait 1 minute for the sample to react. Unscrew the terminal on the top of the cap. If the term
SARS-CoV-2 & Influenza A/B & RSV Combined Antigen Test Kit, intended for the qualitative detection and simultaneous differentiation of novel coronavirus (SARS-CoV-2 antigen), influenza A virus and influenza B virus antigen and /or RSV antigen in samples collected by in vitro nasal swab.
It can be used as a reference for the diagnosis of coronavirus infectious disease (COVID-19) caused by SARS-CoV-2 detected in symptomatic individuals within 7 days of when the syndromes appear. It can also be used as a reference when diagnosing illnesses caused by influenza A/B or RSV.
For in vitro diagnostics only.
The SARS-CoV-2 & Influenza A/B & RSV antigen is qualitatively detected in the samples collected through nasal swabs with the colloidal gold method. After sample addition, SARS-CoV-2 (or Influenza A/B & RSV) antigen in test sample combines with SARS-CoV-2 (or Influenza A/B & RSV) antigen antibody labeled with colloidal gold on the junction plate to form the SARS-CoV-2 (or Influenza A/B & RSV) antigen antibody-colloidal gold complex. By chromatography, the antibody-colloidal gold complex of the SARS-CoV-2 (or Influenza A/B & RSV) antigen diffuses along the nitrocellulose membrane. Within the detection line area, the antibody complex of SARS-CoV-2 (or Influenza A/B & RSV) antigen binds to the antibody enclosed within the detection line area, showing a purple-red band. The SARS-CoV antigen colloidal gold-labeled antibody -2 (or Influenza A/B & RSV) spreads in the QC line area (C) and is captured by sheep anti-mouse IgG to form red bands. At the end of the reaction, the results can be interpreted by visual inspection.
How to use
Use a hand sanitizer to disinfect your hands after washing them.
Clean the table top on which the test will be performed.
Before performing the test, read the instructions for use carefully, and allow the test kit and samples to reach room temperature (20-25°C) before use. The test must be performed at 20-25°C. If the kit is removed from the refrigerator, allow it to return to room temperature (20-25°C) 5 minutes before performing the test.
1. Unscrew the cap of the Sample Processing tube and remove the inner blue cap. The purpose of the blue cap is to prevent the product from escaping during transport, the blue cap must be removed before use. Insert the treatment tube into the hole in the kit or use other objects to hold the treatment tube in place.
2. Open the foil pouch, take out the test cassette and use it as soon as possible, i.e. within 1 hour.
3. Sample collection
to. Carefully remove the sterile nasal swab from its packaging (avoid touching the cotton end of the swab). Insert the nasal swab 2.5 cm (1 inch) into the left nostril.
b. Roll the nasal swab over the nasal walls (mucous membrane) 5 times to ensure that sampling was successful.
c. Repeat the procedure in the right nostril with the same nasal swab, in order to take a sample from both nostrils and make sure that the sampling has taken place correctly.
4. Insert the swab sample into the tube, then break the swab stick and insert the bottom of the swab into the processing tube. Replace the cap.
5. Squeeze the swab 10 times against the side of the tube, then wait 1 minute for the sample to react. Unscrew the terminal on the top of the cap. If the term